Financhill
Buy
69

MCK Quote, Financials, Valuation and Earnings

Last price:
$826.89
Seasonality move :
2.59%
Day range:
$813.00 - $825.88
52-week range:
$565.75 - $895.58
Dividend yield:
0.37%
P/E ratio:
25.71x
P/S ratio:
0.27x
P/B ratio:
--
Volume:
388.5K
Avg. volume:
813.6K
1-year change:
43.17%
Market cap:
$101.9B
Revenue:
$359.1B
EPS (TTM):
$32.12

Analysts' Opinion

  • Consensus Rating
    McKesson Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $939.33, McKesson Corp. has an estimated upside of 13.76% from its current price of $825.73.
  • Price Target Downside
    According to analysts, the lowest downside price target is $760.00 representing 7.96% downside risk from its current price of $825.73.

Fair Value

  • According to the consensus of 13 analysts, McKesson Corp. has 13.76% upside to fair value with a price target of $939.33 per share.

MCK vs. S&P 500

  • Over the past 5 trading days, McKesson Corp. has underperformed the S&P 500 by -0.05% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • McKesson Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • McKesson Corp. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter McKesson Corp. reported revenues of $103.2B.

Earnings Growth

  • McKesson Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter McKesson Corp. reported earnings per share of $8.92.
Enterprise value:
108.8B
EV / Invested capital:
11.80x
Price / LTM sales:
0.27x
EV / EBIT:
22.64x
EV / Revenue:
0.28x
PEG ratio (5yr expected):
0.39x
EV / Free cash flow:
18.10x
Price / Operating cash flow:
17.26x
Enterprise value / EBITDA:
19.95x
Gross Profit (TTM):
$12.5B
Return On Assets:
5.5%
Net Income Margin (TTM):
1.09%
Return On Equity:
--
Return On Invested Capital:
59.37%
Operating Margin:
1.36%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $291.1B $330.2B $387.1B $93.7B $103.2B
Gross Profit $11.6B $12.6B $12.5B $3.1B $3.3B
Operating Income $4.2B $3.8B $4.8B $745M $1.4B
EBITDA $4.9B $4.5B $5.5B $908M $1.6B
Diluted EPS $25.29 $19.29 $32.12 $1.86 $8.92
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $45.6B $46.4B $47.5B $53.3B $59.9B
Total Assets $63.6B $63.1B $66.1B $72.4B $84.2B
Current Liabilities $46.1B $48.4B $51.1B $58.8B $68B
Total Liabilities $63.7B $64.3B $67.6B $75.1B $84.7B
Total Equity -$87M -$1.2B -$1.5B -$2.6B -$578M
Total Debt $7.6B $6.9B $7B $7B $9.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $4.9B $5.1B $6.9B $2.1B $2.4B
Cash From Investing -$973M -$1.1B -$3.9B -$286M -$24M
Cash From Financing -$4.4B -$4B -$1.3B -$1.6B -$961M
Free Cash Flow $4.3B $4.3B $6B $1.9B $2.2B
MCK
Sector
Market Cap
$101.9B
$28.1M
Price % of 52-Week High
92.2%
51.39%
Dividend Yield
0.37%
0%
Shareholder Yield
2.42%
-1.49%
1-Year Price Total Return
43.17%
-17.13%
Beta (5-Year)
0.382
0.518
Dividend yield:
0.37%
Annualized payout:
$2.75
Payout ratio:
9.19%
Growth streak:
12 years

Technicals

8-day SMA
Buy
Level $816.03
200-day SMA
Buy
Level $734.06
Bollinger Bands (100)
Buy
Level 701.44 - 833.74
Chaikin Money Flow
Buy
Level 412.1M
20-day SMA
Sell
Level $825.93
Relative Strength Index (RSI14)
Buy
Level 51.38
ADX Line
Sell
Level 19.33
Williams %R
Sell
Level -0.7492
50-day SMA
Sell
Level $825.91
MACD (12, 26)
Sell
Level -3.85
25-day Aroon Oscillator
Sell
Level -28
On Balance Volume
Neutral
Level 198.7M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (5.8622)
Sell
CA Score (Annual)
Level (-0.6331)
Buy
Beneish M-Score (Annual)
Level (-2.4371)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.9715)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Stock Forecast FAQ

In the current month, MCK has received 10 Buy ratings 3 Hold ratings, and 0 Sell ratings. The MCK average analyst price target in the past 3 months is $939.33.

  • Where Will McKesson Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that McKesson Corp. share price will rise to $939.33 per share over the next 12 months.

  • What Do Analysts Say About McKesson Corp.?

    Analysts are divided on their view about McKesson Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that McKesson Corp. is a Sell and believe this share price will drop from its current level to $760.00.

  • What Is McKesson Corp.'s Price Target?

    The price target for McKesson Corp. over the next 1-year time period is forecast to be $939.33 according to 13 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is MCK A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for McKesson Corp. is a Buy. 10 of 13 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of MCK?

    You can purchase shares of McKesson Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase McKesson Corp. shares.

  • What Is The McKesson Corp. Share Price Today?

    McKesson Corp. was last trading at $826.89 per share. This represents the most recent stock quote for McKesson Corp.. Yesterday, McKesson Corp. closed at $825.73 per share.

  • How To Buy McKesson Corp. Stock Online?

    In order to purchase McKesson Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock